Checklist · Agriculture

Growing, Processing, or Selling Hemp Products: A Practical Checklist

21 U.S.C. § 802

Type
Checklist
Jurisdiction
National
Date
2025-11-24
Topic
Agriculture

This checklist runs a hemp matter from the field to the shelf. It begins with the threshold question that changes every other answer — which measurement governs the material at this stage — and the license and land reporting that determine whether the material was ever lawfully hemp. It covers the sampling window, testing method, measurement uncertainty, and the remediation-or-disposal decision that follows a hot result. It provides a certificate of analysis review protocol, a conversion disclosure sequence, and a full product compliance list covering manufacturing, labeling, packaging, and claims. It closes with the interstate transport packet, the state matrix, contract clauses, insurance, recall readiness, and the defense sequence for a roadside seizure or a conversion prosecution.

Growing, Processing, or Selling Hemp Products: A Practical Checklist

Agriculture > Hemp, CBD, and Intoxicating Cannabinoids | Published 24 November 2025 - Updated 22 June 2026 | UpLaw - uplaw.us

Part 0 — The threshold question

☐ ⚠️ Which measurement governs this material at this stage? ☐ Total THC (cultivation) ☐ Delta-9 concentration (statutory product definition) ☐ ☐ The divergence between them is the entire THCA market and the source of most bad advice. ☐ Material category identified: raw plant ☐ extract ☐ converted cannabinoid ☐ finished product ☐ ☐ Statutory basis confirmed — 21 U.S.C. § 802 ☐ Compliant hemp is excluded from the schedules entirely, not rescheduled. ☐ ⚠️ Did any chemical conversion occur? ☐ Documented ☐ This single fact changes the entire analysis.

Part 1 — Cultivation licensing

☐ Governing program identified: federal ☐ state plan ☐ tribal plan ☐ 7 C.F.R. Part 990 ☐ ☐ License current and covering this crop year ☐ Renewal calendared ☐ ☐ Criminal history requirements satisfied for every key participant ☐ Ineligibility periods checked ☐ ☐ Every lot reported with legal description and geospatial data ☐ ⚠️ An unreported field is an unlawful field regardless of its test result. ☐ Lot boundary changes reported immediately ☐ ☐ Genetics selected with documented THC performance data ☐ Supplier warranty in writing ☐ ☐ Buyer contract executed before planting, with the hot-lot clause ☐ ☐ Crop insurance decision made and documented ☐ Causes of loss confirmed ☐

Part 2 — Sampling and testing

☐ Sampling window dates calendared ☐ ⚠️ Request sampling early in the window, not at the end ☐ Weather delays consume the window and there is no relief. ☐ Sampler's approval status verified ☐ Plant part and compositing method confirmed ☐ ☐ Laboratory meets program requirements ☐ Accreditation scope covers this matrix ☐ ☐ Method identified: liquid chromatography ☐ gas chromatography ☐ The same material can pass on one and fail on the other. ☐ Analyte confirmed: delta-9 alone ☐ total THC (delta-9 plus 0.877 × THCA) ☐ ☐ Measurement of uncertainty reported and applied per the program ☐ ☐ Pre-compliance testing on a schedule during the season ☐ Optional under most programs, indispensable in practice — it converts a surprise into a decision. ☐ Results retained, including failing results ☐ ⚠️ Never retest until a passing number appears. Every version is discoverable. ☐ Written out-of-specification policy adopted before it is needed ☐ ☐ Sample retention period confirmed with the laboratory ☐

Part 3 — Hot lot response

☐ Result compared to the acceptable hemp THC level with uncertainty applied ☐ ☐ Category determined: compliant ☐ negligent violation ☐ above the higher threshold ☐ ☐ Remediation or disposal decision made immediately ☐ Flower removal ☐ whole-plant blending ☐ disposal ☐ ☐ Retesting required after remediation ☐ Scheduled ☐ ☐ ⚠️ Disposal follows the program's method and is documented ☐ Self-help destruction creates a second violation on top of the first. ☐ Buyer notified ☐ Insurer notified ☐ Lender notified where the crop is collateral ☐ ☐ Corrective action plan filed where required ☐ ☐ Cumulative negligent violation count checked ☐ ⚠️ Accumulation produces multi-year ineligibility — the number that ends a business.

Part 4 — Certificate of analysis review

☐ Certificate is for the finished product, not the input ☐ ☐ Lot code on the certificate matches the lot code on the package ☐ ⚠️ Mismatched lot codes are common and are a complete failure of the defense. ☐ Issuing laboratory named, accredited, and within scope ☐ ☐ Method stated ☐ Chromatogram obtained ☐ Sampling record obtained ☐ Uncertainty stated ☐ ☐ Full cannabinoid panel reported, not a single number ☐ ☐ Residual solvents ☐ heavy metals ☐ pesticides ☐ microbials ☐ ☐ Date of analysis within a defensible interval of the shipment date ☐ ☐ ⚠️ A certificate without method, chromatogram, sampling record, and uncertainty is a marketing document, not evidence. ☐ Retest rights and tie-break laboratory identified in the contract ☐

Part 5 — Conversion disclosure

☐ Was the cannabinoid extracted, or produced by chemical conversion of a precursor ☐ ☐ Batch records disclose the conversion ☐ ⚠️ A record that conceals it is far worse than one that discloses it. ☐ Synthetically-derived exposure assessed — 21 C.F.R. Part 1308 ☐ ☐ Analogue exposure assessed — 21 U.S.C. § 813 ☐ Applies only to substances intended for human consumption. ☐ Textual defense preserved: the definition expressly covers derivatives, extracts, cannabinoids, and isomers ☐ ☐ ⚠️ No equitable or necessity exception exists for a substance that is in fact controlled — United States v. Oakland Cannabis Buyers' Cooperative ☐ ☐ Deference posture noted — Loper Bright Enterprises v. Raimondo ☐ ☐ Risk priced in the contract and disclosed to investors ☐

Part 6 — Food and drug compliance

☐ Product ingestible ☐ topical ☐ inhaled ☐ animal ☐ ☐ Drug exclusion rule analyzed — 21 U.S.C. § 321; 21 U.S.C. § 355 ☐ ☐ Food additive status — 21 U.S.C. § 348 ☐ Adulteration consequence understood ☐ ☐ Prohibited acts and penalties — 21 U.S.C. § 331; 21 U.S.C. § 333; seizure 21 U.S.C. § 334; hearing 21 U.S.C. § 335 ☐ ☐ New dietary ingredient path considered and understood not to cure the exclusion — 21 U.S.C. § 350b ☐ ☐ Animal products — 21 U.S.C. § 360b ☐ State feed control ingredient definitions checked ☐ ☐ Food labeling — 21 U.S.C. § 343; 21 C.F.R. Part 101 ☐ ☐ ⚠️ No disease claims anywhere — label ☐ website ☐ social ☐ influencer scripts ☐ customer service ☐ review responses ☐ archived pages ☐ ☐ Misbranded drug exposure understood — 21 U.S.C. § 352 ☐ ☐ ⚠️ Non-enforcement is not legality. The illegality supports consumer claims, defeats coverage, blocks trademarks, kills acquisitions, and justifies processor terminations.

Part 7 — Manufacturing and product

☐ Preventive controls — 21 C.F.R. Part 117 ☐ Hazard analysis ☐ Supply-chain program ☐ Recall plan ☐ ☐ Supplement manufacturing practices — 21 C.F.R. Part 111 ☐ ☐ Electronic records where they are the official record — 21 C.F.R. Part 11 ☐ ☐ Recall procedures — 21 C.F.R. Part 7 ☐ Mock recall run annually ☐ ☐ Lot traceability from input to customer ☐ ⚠️ A firm that cannot identify which lots went where recalls everything. ☐ Label: total THC per serving ☐ per container ☐ serving size ☐ servings ☐ net weight ☐ cannabinoid content as tested ☐ lot code ☐ certificate link ☐ ☐ Child-resistant packaging ☐ No packaging resembling candy or a familiar brand ☐ ⚠️ Copycat packaging drives more legislation and more injury claims than anything else in this field. ☐ Age gating at every channel, including online ☐ Logs retained ☐ ☐ Label approval workflow with a single owner ☐ Every version archived with dates ☐ ☐ Influencer and affiliate agreements restricting claims ☐ Monitoring in place ☐

Part 8 — Transport

☐ Transport packet assembled for every load: producer license ☐ lot report ☐ certificate with sampling and testing dates ☐ bill of lading ☐ manifest tying the load to the tested lot ☐ driver instruction sheet ☐ counsel contact ☐ ☐ Transport-through protection understood ☐ ⚠️ A state may not bar transportation through it; it may bar production and sale within it. ☐ Destination state's rules checked this quarter ☐ ☐ Carrier informed and its own policies checked ☐ ☐ Import or export analysis — 21 C.F.R. Part 1312; customs authority 19 U.S.C. § 1595 ☐ ☐ Cargo coverage for seizure in transit confirmed or known to be absent ☐

Part 9 — The state matrix

☐ Matrix built, dated, and reviewed quarterly ☐ ☐ For each state: lawfulness ☐ THC measurement used ☐ milligram cap per serving and per container ☐ age restriction ☐ packaging and labeling ☐ testing and certificate requirements ☐ licensing or registration ☐ direct-to-consumer shipping ☐ effective dates ☐ ☐ Five regulatory patterns identified for each: prohibition ☐ caps ☐ channeling into cannabis licensure ☐ light-touch ☐ minimal ☐ ☐ State authority basis noted — 21 U.S.C. § 903 ☐ ☐ Constitutional limits checked where a state rule burdens out-of-state sellers — National Pork Producers Council v. Ross; Tennessee Wine and Spirits Retailers Association v. Thomas ☐ ☐ Federal reach over intrastate activity noted — Gonzales v. Raich; Wickard v. Filburn ☐ ☐ ⚠️ Never ship into a state you have not checked this quarter ☐

Part 10 — Contracts

☐ Hot lot allocation ☐ Governing measurement ☐ Laboratory ☐ Sampling protocol ☐ Retest rights and cost ☐ Uncertainty treatment ☐ Remediation before rejection ☐ Rejection timing ☐ ⚠️ Silence here is the most expensive silence in this industry. ☐ Certificate warranties naming laboratory, method, and analytes ☐ Audit and retest rights ☐ Right to chromatograms ☐ ☐ Conversion representation with indemnity ☐ ☐ Definitional change clause — what happens if the law is rewritten during the term ☐ Termination ☐ Inventory ☐ Refunds ☐ Sunk cost allocation ☐ Absent this, the parties litigate impracticability and frustration. ☐ Channel restrictions barring resale into prohibiting states ☐ Indemnity ☐ Audit rights ☐ ☐ Recall cooperation, notification, funding, and cost allocation ☐ ☐ Insurance requirements naming cannabinoid product coverage ☐ Additional insured ☐ Policy pages, not just a certificate ☐ ☐ Genetics and seed warranties with a remedy sized to a lost crop, not to the price of seed ☐ ☐ Testing dispute protocol: tie-break laboratory ☐ who pays ☐ which sample ☐ interim treatment of the material ☐

Part 11 — Insurance

☐ Product liability written knowingly for cannabinoid products ☐ ☐ Exclusions read in the actual policy: controlled substances ☐ cannabis-related operations ☐ products lacking regulatory approval ☐ ⚠️ Any of the three can swallow hemp; the drug-exclusion analysis gives a carrier an argument the CSA does not. ☐ Crop insurance scope and whether a hot test is a covered cause of loss ☐ ☐ Cargo coverage for in-transit seizure ☐ ☐ Recall coverage, separate from product liability ☐ ☐ Directors and officers coverage with regulatory investigation defense ☐ ☐ Every answer confirmed in writing before a claim exists ☐

Part 12 — Tax, banking, and private constraints

☐ Ordinary business deductions available ☐ ⚠️ The provision denying deductions to controlled-substance businesses does not reach hemp — an asymmetry larger than many operators' margins. ☐ Inventory and capitalization rules applied as to any manufacturer ☐ ☐ State excise and sales tax on intoxicating cannabinoid products checked ☐ ☐ Banking relationship documented with full disclosure of the product line ☐ ☐ Payment processor and card network policies reviewed ☐ ⚠️ No statute requires them, no appeal reaches them, and they change without notice. ☐ Marketplace, advertising platform, landlord, and franchisor restrictions identified ☐ ☐ ⚠️ In this industry the binding constraints are frequently private ☐

Part 13 — Intellectual property

☐ Federal trademark registrability assessed against the lawful-use requirement ☐ ☐ State registrations filed ☐ Common-law use documented with dated evidence ☐ ☐ Trade dress and copyright in packaging and content secured ☐ ☐ Registration pursued for unquestionably lawful ancillary goods and services ☐ ☐ Patents considered for extraction, conversion, and formulation processes ☐ ☐ Trade secret protection with actual secrecy measures ☐ ☐ Domain and marketplace enforcement programs, which move faster than litigation ☐

Part 14 — Diligence

☐ License status, governing plan, and full violation history ☐ ☐ Land reports matched to actual production ☐ ☐ Sampling and testing records for every lot in inventory, with methods and chromatograms ☐ ☐ Conversion practices documented honestly ☐ ☐ Finished-product certificates matched to lots on hand ☐ ☐ Shipping history by state, checked against current rules ☐ ☐ Label review against every state of sale ☐ ☐ Every disease claim ever made, including archived pages and influencer content ☐ ☐ Warning letters, state actions, consumer complaints ☐ ☐ Insurance in force and its exclusions ☐ ☐ Trademark position and refused applications ☐ ☐ Contracts: hot lot, definitional change, channel restrictions ☐ ☐ Payment processing history and terminations ☐ ☐ ⚠️ Price a definitional change as a real possibility within the holding period ☐

Part 15 — Criminal defense sequence

☐ Pattern identified: roadside stop ☐ conversion prosecution ☐ unlicensed cultivation ☐ ☐ Method, chromatogram, sampling record, and uncertainty statement obtained first ☐ ☐ Governing measurement standard for this material at this stage established ☐ ☐ Chain of custody and preservation of the seized material examined ☐ ☐ Field test limitations documented ☐ They detect THC without quantifying it and cannot distinguish hemp from marijuana. ☐ Client's compliance program, contemporaneous legal advice, and documented good faith assembled ☐ ☐ Knowledge and intent element developed — Ruan v. United States ☐ It does substantial work where legality is objectively uncertain. ☐ Charging framework reviewed — 21 U.S.C. § 841; possession 21 U.S.C. § 844; forfeiture 21 U.S.C. § 881 ☐ ☐ Registration and scheduling context — 21 U.S.C. § 811; 21 U.S.C. § 812; 21 U.S.C. § 822; 21 U.S.C. § 823 ☐ ☐ Interim release motion filed ☐ A load spoils long before the case resolves.

Part 16 — Civil exposure

☐ Label-accuracy class action risk assessed against actual test data ☐ The most common claim in the industry. ☐ Deceptive practices exposure under state analogues of 15 U.S.C. § 45 principles ☐ ☐ Personal injury exposure, particularly pediatric ingestion and copycat packaging ☐ ☐ No private right of action under the federal statutes ☐ Plaintiffs proceed under state law. ☐ Aggregation posture — Shady Grove Orthopedic Associates, P.A. v. Allstate Insurance Co. ☐ ☐ Preemption defenses assessed realistically — Buckman Co. v. Plaintiffs' Legal Committee bars only fraud-on-the-agency theories ☐ Wyeth v. Levine and Mutual Pharmaceutical Co. v. Bartlett supply no defense for an unapproved product ☐ ☐ Competitor false advertising claims anticipated, frequently from licensed cannabis operators ☐ ☐ Contract-based terminations by landlords, franchisors, and marketplaces treated as contract disputes ☐

Part 17 — Recall readiness

☐ Written recall plan ☐ Mock recall annually ☐ Lot-to-customer identification achievable within hours ☐ ☐ Adverse event and complaint log maintained and reviewed for patterns ☐ ☐ Overconsumption events, particularly pediatric, escalated immediately ☐ ☐ Contamination categories tested for: residual solvents ☐ heavy metals ☐ pesticides ☐ microbials ☐ ☐ Retained samples and all testing records preserved before anything is destroyed ☐ ☐ Notification: regulators where required ☐ distributors and retailers immediately ☐ consumers through channels that reach them ☐ ☐ Product liability and recall carriers notified the same week ☐ ☐ Regulatory hearing procedures understood — 21 U.S.C. § 371; 21 C.F.R. Part 16 ☐

Part 18 — Season calendar

Stage Action Done
Before planting License current; lots reported; genetics warranty; buyer contract with hot-lot clause; insurance decision ☐
Early season Field records by lot: planting date, cultivar, inputs; boundary changes reported immediately ☐
Mid season Pre-compliance testing on a schedule; results documented with the action taken ☐
Window opens Sampling requested early; sampler status, plant part, and compositing confirmed ☐
Result received Compliant → harvest promptly within the defined interval; hot → decide remediation or disposal same day ☐
Harvest Lot identity maintained through drying and storage; no commingling ☐
Sale Transport packet per load; buyer license verified; title and payment terms documented ☐
Post-season Production and disposal reports filed; records retained; cumulative violation count reviewed ☐

☐ ⚠️ Most total losses in this industry trace to a scheduling failure, not a legal one.

Part 19 — Laboratory relationship

☐ Accreditation scope covers cannabinoid analysis in this matrix ☐ ☐ Proficiency testing participation and results available ☐ ☐ Written method validation on file ☐ ☐ Willingness to produce chromatograms and to have an analyst testify ☐ ☐ Written agreement: turnaround ☐ method ☐ analytes ☐ uncertainty reporting ☐ sample retention period ☐ confidentiality ☐ ☐ Conflict checked where the same laboratory serves both supplier and customer ☐ Expect it to be raised in any dispute. ☐ Results interpreted as ranges near the threshold, not as points ☐ ☐ Conversion factor confirmed where total THC is calculated ☐

Part 20 — Retailer obligations

☐ Supplier license, lot certificate, conversion disclosure, and compliance warranty with indemnity for every product ☐ ☐ Certificate matched to the product physically on the shelf ☐ ☐ State matrix maintained for every location and every shipping destination ☐ ☐ Age gating at point of sale and online, with logs ☐ ☐ Copycat packaging refused categorically ☐ ☐ Staff trained on what may not be said ☐ Employee health claims are attributed to the retailer. ☐ Complaint and adverse event log maintained and escalated ☐ ☐ Insurance confirmed in writing to cover cannabinoid products sold at retail ☐ ☐ Written inspection procedure: who is called ☐ what is produced ☐ what is not said ☐

Part 21 — Errors that recur

☐ Treating "hemp-derived" as a legal conclusion rather than a factual claim about a supply chain ☐ ☐ Confusing the cultivation measurement with the product definition ☐ ☐ Assuming federal legality answers the commercial question ☐ ☐ Ignoring the food and drug layer because enforcement is rare ☐ ☐ Accepting a certificate without the method and chromatogram ☐ ☐ Retesting until a passing number appears ☐ ☐ Shipping into an unchecked state ☐ ☐ Letting influencers make claims the company would never make ☐ ☐ Leaving hot-lot and definitional-change risk unallocated ☐ ☐ Assuming existing insurance responds ☐ ☐ Building a capital structure that cannot survive a rewritten definition ☐

Related Documents